Etravirine (Intelence) review from Health Canada

Information about: etravirine (Intelence) for the treatment of HIV-1 infection in treatment-experienced adult patients who have failed prior therapy and have HIV-1 strains resistant to multiple antiretroviral agents, including NNRTIs. From Health Canada. On March 27, 2008, Health Canada issued a Notice of Compliance to Janssen-Ortho Inc. for the drug product Intelence.

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos